- participations in other investigational clinical trials for the treatment or prevention of sars-cov-2 infection - previous or recent covid 19 infection (previously had a sars-cov-2 positive test result or confirmed case of sars-cov-2 infection or positive serology at day 0) - any medical illness - has a congenital immunodeficiency, including specific deficiencies of the interferon-gamma pathway - participants receiving steroids, cytotoxic immunosuppressive agents, radiotherapy. - participants who have received any other immunotherapy. - participants with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction and severe gastric ulcer. - participants receiving allopurinol, indomethacin, colchicine or diuretics. - participants with hematological problems. - known hypersensitivity reactions or wheat allergy - pregnant and lactating females. - refusal to sign the informed consent form - refusal of participation

- participations in other investigational clinical trials for the treatment or prevention of sars-cov-2 infection - previous or recent covid 19 infection (previously had a sars-cov-2 positive test result or confirmed case of sars-cov-2 infection or positive serology at day 0) - any medical illness - has a congenital immunodeficiency, including specific deficiencies of the interferon-gamma pathway - participants receiving steroids, cytotoxic immunosuppressive agents, radiotherapy. - participants who have received any other immunotherapy. - participants with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction and severe gastric ulcer. - participants receiving allopurinol, indomethacin, colchicine or diuretics. - participants with hematological problems. - known hypersensitivity reactions or wheat allergy - pregnant and lactating females. - refusal to sign the informed consent form - refusal of participation